
Isis A. D. Ghali
Examiner (ID: 231)
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1611, 1615 |
| Total Applications | 1721 |
| Issued Applications | 501 |
| Pending Applications | 322 |
| Abandoned Applications | 932 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16596562
[patent_doc_number] => 20210023093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => Transdermal Delivery
[patent_app_type] => utility
[patent_app_number] => 17/069571
[patent_app_country] => US
[patent_app_date] => 2020-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17069571
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/069571 | Transdermal Delivery | Oct 12, 2020 | Abandoned |
Array
(
[id] => 16596561
[patent_doc_number] => 20210023092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => Transdermal Delivery
[patent_app_type] => utility
[patent_app_number] => 17/069758
[patent_app_country] => US
[patent_app_date] => 2020-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17069758
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/069758 | Transdermal Delivery | Oct 12, 2020 | Abandoned |
Array
(
[id] => 16581278
[patent_doc_number] => 20210015680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => THERAPEUTIC ELASTIC BANDAGE FOR MODULATING THE ENDOCANNABINOID SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/062379
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17062379
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/062379 | THERAPEUTIC ELASTIC BANDAGE FOR MODULATING THE ENDOCANNABINOID SYSTEM | Oct 1, 2020 | Abandoned |
Array
(
[id] => 16581564
[patent_doc_number] => 20210015966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => Antibacterial Cellulose Hydrogels and Preparation Method therefor
[patent_app_type] => utility
[patent_app_number] => 17/035705
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17035705
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/035705 | Antibacterial Cellulose Hydrogels and Preparation Method therefor | Sep 28, 2020 | Abandoned |
Array
(
[id] => 17441987
[patent_doc_number] => 20220062492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => Sealant Dressing with Protected Reactive Components
[patent_app_type] => utility
[patent_app_number] => 17/007712
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17007712
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/007712 | Sealant dressing with protected reactive components | Aug 30, 2020 | Issued |
Array
(
[id] => 17741366
[patent_doc_number] => 11389409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Transdermal device comprising acetaminophen prodrug
[patent_app_type] => utility
[patent_app_number] => 17/005901
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21436
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17005901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/005901 | Transdermal device comprising acetaminophen prodrug | Aug 27, 2020 | Issued |
Array
(
[id] => 16596488
[patent_doc_number] => 20210023019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => DERMAL PATCH FOR TRANSDERMAL ADMINISTRATION OF GHRELIN PATHWAY BLOCKER
[patent_app_type] => utility
[patent_app_number] => 16/938234
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938234
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/938234 | DERMAL PATCH FOR TRANSDERMAL ADMINISTRATION OF GHRELIN PATHWAY BLOCKER | Jul 23, 2020 | Abandoned |
Array
(
[id] => 16883627
[patent_doc_number] => 20210169822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => TRANSDERMAL DRUG DELIVERY METHOD AND SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/933836
[patent_app_country] => US
[patent_app_date] => 2020-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16933836
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/933836 | TRANSDERMAL DRUG DELIVERY METHOD AND SYSTEM | Jul 19, 2020 | Abandoned |
Array
(
[id] => 18517567
[patent_doc_number] => 11707437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Topical formulations with resiniferatoxin nanoparticles and methods
[patent_app_type] => utility
[patent_app_number] => 16/925551
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 8466
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16925551
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/925551 | Topical formulations with resiniferatoxin nanoparticles and methods | Jul 9, 2020 | Issued |
Array
(
[id] => 18842671
[patent_doc_number] => 20230405075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => PREPARATIONS CONTAINING MITRAGYNE EXTRACT OR ITS ISOLATED ALKALOIDS AND CANNABIS EXTRACT OR ITS ISOLATED CANNABINOIDS, AND COSMETIC AND/OR PHARMACEUTICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/024788
[patent_app_country] => US
[patent_app_date] => 2020-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024788
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024788 | PREPARATIONS CONTAINING MITRAGYNE EXTRACT OR ITS ISOLATED ALKALOIDS AND CANNABIS EXTRACT OR ITS ISOLATED CANNABINOIDS, AND COSMETIC AND/OR PHARMACEUTICAL USE THEREOF | Jul 7, 2020 | Pending |
Array
(
[id] => 16375058
[patent_doc_number] => 20200323900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => METHODS FOR TREATING NEUROMUSCULAR JUNCTION-RELATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/913646
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913646
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913646 | METHODS FOR TREATING NEUROMUSCULAR JUNCTION-RELATED DISEASES | Jun 25, 2020 | Abandoned |
Array
(
[id] => 16466739
[patent_doc_number] => 20200368276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => GUT-SELECTIVE SEQUESTERING AGENTS FOR THE TREATMENT AND PREVENTION OF AUTISM AND RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/898201
[patent_app_country] => US
[patent_app_date] => 2020-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22660
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16898201
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/898201 | Gut-selective sequestering agents for the treatment and prevention of autism and related disorders | Jun 9, 2020 | Issued |
Array
(
[id] => 17235442
[patent_doc_number] => 11179305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Topical compositions
[patent_app_type] => utility
[patent_app_number] => 16/898120
[patent_app_country] => US
[patent_app_date] => 2020-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29937
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16898120
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/898120 | Topical compositions | Jun 9, 2020 | Issued |
Array
(
[id] => 17273039
[patent_doc_number] => 20210379237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => Napped Coated Wound Dressing
[patent_app_type] => utility
[patent_app_number] => 16/895150
[patent_app_country] => US
[patent_app_date] => 2020-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16895150
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/895150 | Napped coated wound dressing | Jun 7, 2020 | Issued |
Array
(
[id] => 17775109
[patent_doc_number] => 20220241458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => Removable Film-Forming Gel Compositions Featuring Adhesion Promoters
[patent_app_type] => utility
[patent_app_number] => 17/612132
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/612132 | Removable Film-Forming Gel Compositions Featuring Adhesion Promoters | May 28, 2020 | Pending |
Array
(
[id] => 16310750
[patent_doc_number] => 20200289488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => TRANSDERMAL ADMINISTRATION OF FENTANYL AND ANALOGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/885429
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16885429
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/885429 | TRANSDERMAL ADMINISTRATION OF FENTANYL AND ANALOGS THEREOF | May 27, 2020 | Abandoned |
Array
(
[id] => 17480438
[patent_doc_number] => 20220087942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => ENTERIC TABLET CONTAINING DIMETHYL FUMARATE
[patent_app_type] => utility
[patent_app_number] => 17/441256
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441256
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/441256 | ENTERIC TABLET CONTAINING DIMETHYL FUMARATE | May 20, 2020 | Abandoned |
Array
(
[id] => 16504701
[patent_doc_number] => 20200383957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => DEPOT FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/877957
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877957
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/877957 | DEPOT FORMULATIONS | May 18, 2020 | Abandoned |
Array
(
[id] => 17312700
[patent_doc_number] => 20210401748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => Powder for oral suspension containing lamotrigine
[patent_app_type] => utility
[patent_app_number] => 16/974343
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5926
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16974343
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/974343 | Powder for oral suspension containing lamotrigine | May 17, 2020 | Abandoned |
Array
(
[id] => 17176826
[patent_doc_number] => 11154053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Compositions for controlling phytoplankton contamination
[patent_app_type] => utility
[patent_app_number] => 15/930141
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 35
[patent_no_of_words] => 20302
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930141
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930141 | Compositions for controlling phytoplankton contamination | May 11, 2020 | Issued |